ARCHIVES

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

FDA Designates Zometa For Priority Review.

November 30, 2001

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013